Last updated on July 2019

Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A


Brief description of study

The primary purpose of the study is to compare the efficacy and safety of canakinumab versus placebo as adjuvant therapy in adult subjects with stages AJCC/UICC v. 8 II -IIIA and the subset of IIIB (T>5cm N2 disease) completely resected (R0) non-small cell lung cancer (NSCLC).

Clinical Study Identifier: NCT03447769

Find a site near you

Start Over

Texas Oncology P A SC-3

Dallas, TX United States
  Connect »

Florida Cancer Specialists North

Saint Petersburg, FL United States
  Connect »

Sansum Clinic

Santa Barbara, CA United States
  Connect »

US Oncology, P.A.

Tyler, TX United States
  Connect »

Texas Oncology P A

Dallas, TX United States
  Connect »

Florida Cancer Specialists

Fort Myers, FL United States
  Connect »

Florida Cancer Specialists

West Palm Beach, FL United States
  Connect »

Maryland Oncology Hematology P A

Silver Spring, MD United States
  Connect »

HCA Midwest Division

Kansas City, MO United States
  Connect »

US Oncology P A

Tyler, TX United States
  Connect »

Novartis Investigative Site

Marseille cedex 20, France
  Connect »

Novartis Investigative Site

Montpellier cedex 5, France
  Connect »

Novartis Investigative Site

Saint-Herblain Cédex, France
  Connect »

Novartis Investigative Site

Vandoeuvre-les-Nancy cedex, France
  Connect »

Novartis Investigative Site

Georgsmarienhuette, Germany
  Connect »

Novartis Investigative Site

Guatemala City, Guatemala
  Connect »

Novartis Investigative Site

Cheongju si, Korea, Republic of
  Connect »

Novartis Investigative Site

Seoul, Korea, Republic of
  Connect »

Novartis Investigative Site

Jeollanam-do, Korea, Republic of
  Connect »

Novartis Investigative Site

Nizhny Novgorod, Russian Federation
  Connect »

Novartis Investigative Site

Ryazan, Russian Federation
  Connect »

Novartis Investigative Site

Saint Petersburg, Russian Federation
  Connect »

Novartis Investigative Site

St Petersburg, Russian Federation
  Connect »

Novartis Investigative Site

Santiago de Compostela, Spain
  Connect »

Novartis Investigative Site

Pendik / Istanbul, Turkey
  Connect »

Novartis Investigative Site

Cheltenham, United Kingdom
  Connect »

Novartis Investigative Site

Guildford, United Kingdom
  Connect »

Novartis Investigative Site

Birmingham, United Kingdom
  Connect »

Novartis Investigative Site

Nottingham, United Kingdom
  Connect »

Novartis Investigative Site

Scunthorpe, United Kingdom
  Connect »

Novartis Investigative Site

Stoke-on-Trent, United Kingdom
  Connect »

Novartis Investigative Site

Saint-Herblain Cédex, France
  Connect »

Novartis Investigative Site

Saint-Herblain Cédex, France
  Connect »

Novartis Investigative Site

Saint-Herblain Cédex, France
  Connect »

Novartis Investigative Site

Saint-Herblain Cédex, France
  Connect »

Novartis Investigative Site

Saint-Herblain Cédex, France
  Connect »

Novartis Investigative Site

Saint-Herblain Cédex, France
  Connect »

Novartis Investigative Site

Cambridge, United Kingdom
  Connect »

Novartis Investigative Site

Saint-Herblain Cédex, France
  Connect »

Novartis Investigative Site

Saint-Herblain Cédex, France
  Connect »

Novartis Investigative Site

Saint-Herblain Cédex, France
  Connect »

Novartis Investigative Site

Saint-Herblain Cédex, France
  Connect »

Novartis Investigative Site

Saint-Herblain Cédex, France
  Connect »

Novartis Investigative Site

Saint-Herblain Cédex, France
  Connect »

Novartis Investigative Site

Saint-Herblain Cédex, France
  Connect »

Novartis Investigative Site

Saint-Herblain Cédex, France
  Connect »

Novartis Investigative Site

Arkhangelsk, Russian Federation
  Connect »

Novartis Investigative Site

Pushkin Saint Petersburg, Russian Federation
  Connect »

Novartis Investigative Site

Saint-Herblain Cédex, France
  Connect »

Novartis Investigative Site

Saint-Herblain Cédex, France
  Connect »

Novartis Investigative Site

Saint-Herblain Cédex, France
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.